Singapore updates device guides as Jan 2012 implementation deadline nears for mandatory framework
This article was originally published in SRA
Singapore's Health Sciences Authority has updated its medical devices guidelines on product registration and declaration of conformity assessment1,2 ahead of the January 2012 deadline by which a mandatory medtech regulatory framework will be implemented in full3.
You may also be interested in...
Citing challenges posed by the COVID-19 pandemic, EU regulators have extended the deadline for companies to finish nitrosamine-related risk evaluations.
The Australian health care products regulator is inviting feedback on proposed measures to clarify the boundary for software-based products that are captured under the regulatory framework for medical devices.
A draft EU guideline explains how companies can ensure that data from ongoing clinical trials remains relevant for regulatory decision-making despite problems posed by the COVID-19 pandemic.